Try our beta test site

Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) (SGN+Benda)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2017 by Columbia University
Sponsor:
Collaborators:
British Columbia Cancer Agency
Princess Margaret Hospital, Canada
Information provided by (Responsible Party):
Owen A. O'Connor, Columbia University
ClinicalTrials.gov Identifier:
NCT01657331
First received: August 2, 2012
Last updated: February 1, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)